← All trials
NCT00127959
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2004
- Primary completion
- —
- Completion date
- Aug 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 24
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- International Antiviral Therapy Evaluation Center (IATEC)Lead sponsor
- HIV-NAT Thai Red Cross AIDS Research CenterOverall official - principal investigator
- Gilead SciencesCollaborator
- University of AmsterdamOverall official - principal investigator
- University of AmsterdamStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.